AST 18th Annual Scientific Meeting

May 15-19, 1999 · Sheraton Hotel and Towers · Chicago, IL

Concurrent Session 16:
Lymphocyte Activation I

Chairs: JW Kupiec-Weglinski and Olivia Martinez


Return to the Agenda:

NOTE: You can search this page by using your browser's "Find" function
(under the "Edit" menu in Netscape Navigator/Communicator and Microsoft Internet Explorer)


11:00 #459 Alterations of T cell signaling pathways in allogeneic rat hosts rendered tolerant by oral administration of allochimeric class I MHC proteins. Young Investigator Award

M Wang, J Yu, K Akioka, Y Zhang, R Kirken, SM Stepkowski and BD Kahan, Houston, TX

11:10 #460 Antigen reactivated regula-tory T cells maintain infectious tolerance in transplant recipients. Young Investigator Award

B Reemtsen, H Kato, M Ghobrial, JA Goss, HD Volk, RW Busuttil and JW Kupiec-Weglinski, Los Angeles, CA and Berlin, Germany

11:20 #461 Independent roles for CD4+ and CD8+ T cells in initiating rejection of allogeneic hepatocytes.

D Gao, J Li, CG Orosz and GL Bumgardner, Columbus, OH

11:30 #462 Quantitative analysis of NFkB and IkB gene transcription within mouse cardiac allografts.

V Csizmadia, W Gao, R Tao, L Turka and WW Hancock, Cambridge; Boston, MA and Philadelphia, PA

11:40 #463 The regulation of TRANCE expression on T cells in vitro and in vivo during acute heart allograft rejection and allograft tolerance.

R Josien, B Wong, J-M Heslan, H-L Li, J-P Soulillou, M-C Cuturi, R Steinman and Y Choi, Nantes, France and New York, NY

11:50 #464 TNP-470, an anti-angiogenesis agent, is a potent inhibitor of human CD4+ T cell proliferation.

MD Denton, C Magee, S Alexander, MH Sayegh and DM Briscoe, Boston, MA

12:00 #465 Inhibition of JAK3 tyrosine kinase by PNU 15804 blocks heart allograft rejection.

M-E Wang, R Kirken, F Behbod, SM Stepkowski and BD Kahan, Houston, TX

12:10 #466 The alloantibody response is dependent upon the classical pathway of complement activation.

JE Marsh, MC Carroll and SH Sacks, London, UK and Boston, MA

12:20 #467 The role of CD40 in vascular rejection: evidence against the involvement of alloantibody.

SM Ensminger, O Witzke, BM Spriewald, H Sorensen, PJ Morris, ML Rose, A Rahemtulla and KJ Wood, Oxford and Middlesex, UK

Back to Top

Return to the Agenda

AST Home

Copyright ©1997-2000, AST
last revised: 10 April 1999

Site created by SLACK Incorporated
E-mail the Webmaster with questions or comments.